Bio for Winton Gibbons

Winton Gibbons

My background merges industry, consulting, and financial services, predominantly for innovative clinical diagnostic, life science, and therapeutic companies. These have been based on biotechnology, nanotechnology, and microfluidics, as well as novel biomarkers.



Corporate Development Senior Vice President 
Agena Bioscience (2015 – 2016) Genetic Testing (Mass Spectrometry)
CEO & President  
Siloam Biosciences (2014 – 2015) Clinical Diagnostics (Microfluidics)
Business Development Senior Vice President
Nanosphere (2007 – 2013) (acquired by Luminex) Clinical Diagnostics (Nanotechnology)
Strategic Marketing & Product Management Senior Vice President
Biosite (2005 – 2007) (acquired by Alere) Clinical Diagnostics (Biotechnology)
Healthcare Equity Research Analyst, Principal, and Group Head
William Blair & Company (1997 – 2005)  
Strategy & Business Development Vice President
Boehringer Mannheim (1994 – 1997) (acquired by Roche) Diagnostics and Pharmaceuticals
Management Services (internal consulting) Director
Merck & Co. (1993 – 1994) Pharmaceuticals
Management Consulting Engagement Manager and Consultant
McKinsey & Company (1989 – 1993)  



University of Chicago Booth School of Business MBA Finance
Duke University BS Chemistry




Investor Board for the Innovation and New Ventures Office of Northwestern University (technology transfer) from 2010 to present.
Advisory Board and Guest Lecturer for the Kellogg School of Management – Center for Biotechnology – 1998 to 2010.
AACC annual Financial Analyst Briefing organizing committee from 2000 to present.


Chicago Innovation Mentors program – a consortium of University of Chicago, Northwestern University and University of Illinois. Mentor team leader for a urological in-vivo diagnostic.


Patent filings – Four published applications, numerous other disclosures and filings.
One thousand financial reports and commentaries.
Quoted by Biocentury, Bloomberg and Bloomberg TV, Boston Herald, CBS Market Watch, Chicago Tribune, CNBC TV, Dow Jones, Forbes, In Vivo, Investor’s Business Daily, MSNBC TV, Nature, New York Times, PBS, Reuters, San Francisco Chronicle,,, USA Today, Wall Street Journal, and Washington Post.